pre-seed
Stage
About
Developing a home diagnostic test for vaginal infections that detects active bacterial or yeast infections (including mixed cases), for discreet, rapid, at-home results. Cites that 66% of women misdiagnose their own yeast infections and 42% are misdiagnosed by an OB/GYN; over 900 million women affected by bacterial vaginosis and/or vulvovaginal candidiasis annually. Pre-investment stage as of 2023 reporting, seeking first investors.
Explore shealed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.